Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neural Regulation01:37

Neural Regulation

44.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.7K
Amyloid Fibrils03:03

Amyloid Fibrils

12.9K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-ancestry analysis of <i>POLG</i> variants in Parkinson's disease.

medRxiv : the preprint server for health sciences·2026
Same author

Rare-Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

PD GENEration: An International Parkinson's Disease Genetic Research Study.

medRxiv : the preprint server for health sciences·2026
Same author

mTOR Inhibition Drives Mutation-Specific Remodeling of Lysosomal and Autophagic Pathways and GCase Activity in PBMC-Derived Macrophages from Patients with GBA1-Associated Parkinson's Disease.

Current issues in molecular biology·2026
Same author

The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta-Analysis.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Glucosylsphingosine (Lyso-Gb1) Dynamics in Untreated States in Gaucher Disease.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Mar 28, 2026

Detection of Disease-associated &#945;-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated &#945;-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.4K

The GBA1 p.E427K (p.E388K) Variant is a Risk Factor for Synucleinopathies: A Meta-Analysis.

Leah V Chifamba1,2, Sitki Cem Parlar1,2, Emma N Somerville1,2

  • 1The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada.

Medrxiv : the Preprint Server for Health Sciences
|March 27, 2026
PubMed
Summary
This summary is machine-generated.

The GBA1 p.E427K variant increases the risk of synucleinopathies, including Parkinson's disease. This finding highlights its importance in genetic studies and clinical trials for these neurodegenerative disorders.

More Related Videos

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.2K
Recombinant &#945;- &#946;- and &#947;-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
09:36

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays

Published on: August 13, 2017

7.1K

Related Experiment Videos

Last Updated: Mar 28, 2026

Detection of Disease-associated &#945;-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated &#945;-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.4K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.2K
Recombinant &#945;- &#946;- and &#947;-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
09:36

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays

Published on: August 13, 2017

7.1K

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • Glucocerebrosidase gene (GBA1) variants are established genetic risk factors for synucleinopathies.
  • Parkinson's disease (PD) is a major synucleinopathy.
  • The specific role of the GBA1 p.E427K variant in disease risk was previously unclear.

Purpose of the Study:

  • To investigate the association between the GBA1 p.E427K variant and the risk of developing synucleinopathies.

Main Methods:

  • A comprehensive meta-analysis of case-control studies was conducted.
  • Data were aggregated from published literature, open-access databases, and large-scale cohorts.
  • Pooled odds ratios (ORs) were calculated using a random-effects model.

Main Results:

  • The GBA1 p.E427K variant was significantly associated with an increased risk of synucleinopathies (pooled OR = 1.87, P = 0.001).
  • Analysis included data from 67,484 patients and 124,079 controls.
  • Reduced glucocerebrosidase enzyme activity was observed in carriers of the variant.

Conclusions:

  • The GBA1 p.E427K variant is confirmed as a significant risk factor for synucleinopathies.
  • This variant warrants consideration in future genetic research and clinical trials related to synucleinopathies.